Soheila Aghlmandi
Biographic Data
| ID | 7963668 |
|---|---|
| NAME | Soheila Aghlmandi |
| GIVEN NAMES | Soheila |
| FAMILY NAME | Aghlmandi |
| SIGNATURE | AGHLMANDI S |
| AFFILIATIONS | University Hospital of Basel |
| ORCID | 0000-0003-0180-3246 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2021 |
| H-INDEX | 0 |
Does Hippocampal Volume Predict Transition to Psychosis in a High-Risk Group? A Meta-Analysis
Schizophrenia has a prodromal phase of several years in most patients, making it possible to identify patients at clinical high risk (CHR) for developing the disorder. So far, these individuals are identified based on clinical criteria alone, and there is no reliable biomarker for predicting the transition to psychosis. It is well-established that reductions in brain volume, especially in the hippocampus, are associated with schizophrenia. Theref…
No prominent works on this page.
Does Hippocampal Volume Predict Transition to Psychosis in a High-Risk Group? A Meta-Analysis
Schizophrenia has a prodromal phase of several years in most patients, making it possible to identify patients at clinical high risk (CHR) for developing the disorder. So far, these individuals are identified based on clinical criteria alone, and there is no reliable biomarker for predicting the transition to psychosis. It is well-established that reductions in brain volume, especially in the hippocampus, are associated with schizophrenia. Theref…
Biology (1 work) · Biomarker (1 work) · Functional Brain Connectivity Studies (1 work) · Hippocampal formation (1 work) · Hippocampus (1 work) · Internal Medicine (1 work) · Medicine (1 work) · Meta-analysis (1 work) · Neuroscience (1 work) · Oncology (1 work)